Bright Minds Biosciences Inc. · CSE:DRUG
Cormorant Asset Management, LP reported a 9.71% stake in Bright Minds Biosciences Inc. (Schedule 13G/A)
Event Apr 28, 2026 · Filed Apr 30, 2026
Cormorant Asset Management, LP reported a 9.71% stake in Bright Minds Biosciences Inc., 950,000 shares, as a passive investor on Apr 28, 2026. Filed Apr 30, 2026 (Schedule 13G/A).
- Stake
- 9.71%
- Shares
- 950,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Cormorant Asset Management, LP | 9.71% | 950,000 |
| Chen Bihua | 9.71% | 950,000 |
Source
Related
- Bright Minds Biosciences Inc.
- Cormorant Asset Management, LP
- Bright Minds Biosciences Inc. shareholders
- Schedule 13G/A · Cormorant Asset Management, LP · Aug 14, 2026
- Schedule 13G/A · Cormorant Asset Management, LP · Feb 6, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13D/A · Ian McDonald · Jul 2, 2026
- Schedule 13G · Vestal Point Capital, LP · May 15, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026